BS
IDNA icon

Banco Santander’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Banco Santander’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Hold
7,560
– – ﹤0.01% 464
2026
Q1 		$220K Buy
+7,560
New +$219K ﹤0.01% 448

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Banco Santander's IDNA Position: Q2 2026 in Review

Banco Santander held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q2 2026 at 7,560 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #464.

Banco Santander first reported a position in IDNA in Q1 2026 and has held it in 2 quarters since. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

  • Banco Santander held 7,560 shares of iShares Genomics Immunology and Healthcare ETF worth $255K as of Q2 2026.
  • Banco Santander left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q2 2026.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Banco Santander's portfolio in Q2 2026, its #464 holding.
  • Banco Santander first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2026 and has held it in 2 quarters since.
  • 66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.